Health ❯ Obesity ❯ Treatment

Medications

GLP-1 Drugs Semaglutide GLP-1 Therapies GLP-1 Agonists GLP-1 Receptor Agonists GLP-1 GLP-1 Therapy GLP-1 Treatments Guidelines Nutritional Deficiencies Liraglutide Oral Semaglutide Poviztra GLP-1 Medications Wegovy Long-term Effects Obesity Medications Risks of Counterfeits GLP-1 Analogues Lifestyle Changes Weight-loss drugs Weight Loss Drugs Weight Loss Jabs Injectable Drugs

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO’s conditional endorsement comes with a warning of severe access shortfalls by 2030.

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide